Press releases

July 21, 2021

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

July 08, 2021

Novamind Selected as Research Site for Bionomics’ PTSD Clinical Trial

June 30, 2021

Novamind Launches Psychedelic Therapy Frontiers Podcast

June 23, 2021

Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer

June 17, 2021

Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company

June 15, 2021

Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021

June 10, 2021

Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers

June 01, 2021

Novamind Reports Fiscal Q3 Financial Results and Operating Highlights

May 18, 2021

Novamind Opens Client Care Center to Support High Demand for Treatments

May 04, 2021

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics